A study on NAFLD revealed that naringenin enhanced TFAM expression by upregulating PGC1-α, thereby promoting mitochondrial biogenesis in fat and muscle cells [25]. This evidence concerns the gene TFAM and metabolic dysfunction-associated steatotic liver disease.